Article

2005 annual meeting to spotlight technology advances

The 2005 American Academy of Ophthalmology annual meeting will highlight the promise and hope of new advances in technology that are moving quickly out of the laboratory and to your patients.

Get up to speed at the 109th annual meeting in Chicago (Oct. 15 to 18) with several new courses; a new spotlight session, Glaucoma Care and Technology; the AAOE general session, Integrating Innovation Into Your Practice; as well as the opening session, which features keynote speaker Francis S. Collins, MD, PhD.

Dr. Collins shepherded the Human Genome Project through many of its major goals, including the 2003 completion of the fully sequenced human genome. He will open the annual meeting on Oct. 16 by sharing his thoughts on how advances in genomic science can be applied to the prevention, diagnosis, and treatment of eye diseases. Dr. Collins predicts a true revolution in patient care in the coming years, as new research enables the development of screening tests and tailor-made therapies for individual patients.

A captivating speaker who is often tapped by the media to explain the Human Genome Project and genomic medicine, you won't want to miss Dr. Collins' presentation at the opening session, 8:30 to 10 a.m. on Sunday, Oct. 16.

Other program highlights Further program highlights include:

Subspecialty days Subspecialty Day will once again offer an intensive review of the latest advances that can be immediately applied in your practice. We offer six comprehensive meetings this year:

Attendees will again have the chance to "float" among meetings. Register for the Retina or Refractive Surgery meetings and float among all six on Friday and Saturday. Glaucoma, Neuro-Ophthalmology, Pediatric Ophthalmology, and Uveitis meeting registrants can float among all six meetings on Saturday only.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.